(Q43961146)

28 November 2017

Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation (English)

1 reference

28 November 2017

1 reference

1 reference

R R Ruffolo

1

1 reference

PubMed ID

1974499

28 November 2017

C F Sauermelch

series ordinal

2

1 reference

PubMed ID

1974499

28 November 2017

R N Willette

series ordinal

3

1 reference

28 November 2017

1 January 1990

1 reference

European Journal of Clinical Pharmacology

28 November 2017

1 reference

28 November 2017

38 Suppl 2

1 reference

28 November 2017

S112-4

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01409477

28 November 2017

0 references

cites work

Vascular effects of carvedilol, a new beta-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery

1 reference

12 December 2020

In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol

1 reference

12 December 2020

Antihypertensive compounds with combined actions.

1 reference

12 December 2020

Studies on the mode of vasodilating action of carvedilol

1 reference

12 December 2020

Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties

1 reference

12 December 2020

Laser Doppler measurements of blood flow in skin tissue

1 reference

12 December 2020

A new molecule with vasodilating and beta-adrenoceptor blocking properties.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01409477

1 reference

28 November 2017

1 reference

PubMed ID

1974499